Filter
2426
Filtered Results: 2426
Text search:
causes
of
malaria
Featured
Recommendations
246
New Publications
820
Language
Document type
No document type
1590
Studies & Reports
363
Guidelines
212
Manuals
91
Strategic & Response Plan
73
Training Material
43
Fact sheets
24
Situation Updates
15
Resource Platforms
7
Infographics
5
Brochures
2
Online Courses
1
Countries / Regions
India
105
Global
93
Ethiopia
85
Kenya
83
Sierra Leone
82
Malawi
74
Liberia
70
Uganda
69
Nigeria
62
Tanzania
60
Rwanda
55
Zambia
54
Africa
49
Nepal
48
Ghana
44
South Africa
40
Congo, Democratic Republic of
37
Namibia
36
Myanmar / Burma
36
Bangladesh
32
Western and Central Europe
28
Latin America and the Carribbean
24
Mozambique
23
Philippines
22
Zimbabwe
21
Haiti
21
South Sudan
21
East and Southern Africa
20
Indonesia
19
Guinea
18
Senegal
18
Cameroon
18
Eastern Europe
18
Cambodia
17
Lesotho
17
West and Central Africa
16
South–East Asia Region
16
Asia
15
Eswatini/ Swaziland
13
Botswana
12
Burkina Faso
11
Syria
9
Middle East and North Africa
9
Somalia
8
Pakistan
8
Yemen
8
Venezuela
8
Papua New Guinea
7
Afghanistan
6
Sudan
6
Brazil
6
Vietnam
6
Thailand
5
Ukraine
5
Madagascar
5
Laos
5
Benin
4
Peru
4
Colombia
4
Western Pacific Region
4
Eastern Europe and Central Asia
4
Tajikistan
4
Jordan
3
Lebanon
3
Argentina
3
Bolivia
3
Albania
3
Russia
3
Georgia
3
Mali
2
Niger
2
Togo
2
Egypt
2
Chad
2
China
2
Malaysia
2
Central African Republic
2
North Macedonia
2
Burundi
2
Angola
2
Sri Lanka
2
Paraguay
2
Timor Leste/ East Timor
2
Qatar
2
Iran
2
Guinea-Bissau
1
Côte d’Ivoire / Ivory Coast
1
Saudi Arabia
1
Iraq
1
Germany
1
Turkey
1
Gambia
1
Singapore
1
Serbia
1
Honduras
1
Libya
1
Chile
1
Other region
1
Bhutan
1
Palestine
1
Djibouti
1
Armenia
1
Southern Africa
1
Moldova
1
Turkmenistan
1
Japan
1
Maldives
1
Mauritius
1
Authors & Publishers
Publication Years
Category
Countries
1172
Clinical Guidelines
200
Women & Child Health
172
Public Health
141
Key Resources
93
Capacity Building
50
Pharmacy & Technologies
19
Toolboxes
HIV
162
TB
131
Planetary Health
101
COVID-19
89
Ebola
74
Mental Health
70
AMR
69
Global Health Education
65
Caregiver
54
NTDs
53
Disability
52
Pharmacy
49
Rapid Response
45
Conflict
35
Health Financing Toolbox
31
Natural Hazards
25
NCDs
19
Refugee
15
Cholera
10
Zika
8
Social Ethics
8
Polio
7
Specific Hazards
2
Typhoon
1
Health Financing
1
Myanmar is one of the world’s 22 high tuberculosis (TB) burden countries, and supporting TB control in Myanmar is a global priority. This report reflects the findings, discussions, conclusions and recommendations ... the fourth international review mission of the Myanmar National TB Programme (NTP), which brought together international and national partners to review progress in TB control and to offer guidance on future TB control directions and efforts.
A high-quality national disease prevalence survey completed in 2010 demonstrated a TB disease burden two to three times higher than anticipated on the basis of previous surveys. In 2011 about 200 000 adults and children will have developed TB, including 20 000 HIV infected and 9000 suffering from MDR-TB, both of which will require additional care and costly treatment. TB remains among the top killers of adults, and more women die of TB than from maternal causes.
A high-quality national disease prevalence survey completed in 2010 demonstrated a TB disease burden two to three times higher than anticipated on the basis of previous surveys. In 2011 about 200 000 adults and children will have developed TB, including 20 000 HIV infected and 9000 suffering from MDR-TB, both of which will require additional care and costly treatment. TB remains among the top killers of adults, and more women die of TB than from maternal causes.
It is Zika virus (ZIKV) that most often causes these neurological effects it appears to be the only arbovirus than can cause congenital malformations such as microcephaly. In any case, more scientific tests are needed to establish the causal relatio...
Int J Hyg Environ Health. 2019 Jun; 222(5): 765–777. doi: 10.1016/j.ijheh.2019.05.004;
To develop updated estimates in response to new exposure and exposure-response data of the
burden of diarr...
Evidence for technical update of pocket book recommendations. Newborn conditions, dysentery, pneumonia, oxygen use and delivery, common causes of f...
To improve survival and quality of life among the 2.5 million children living with HIV, a comprehensive package of prevention, care and treatment is required. This package should include management ...
This Training module on malaria elimination has been developed by WHO to support health professionals in planning, managing, monitoring and evaluating malaria elimination programmes.
Supporting exe...
TNew data from the World Health Organization reveal that the COVID-19 pandemic has disrupted malaria services, leading to a marked increase in cases and deaths.
According to WHO’s latest World malaria...
These Blended Learning Modules cover the full range of health promotion, disease prevention, basic management and essential treatment protocols to improve and protect the health of rural communities...
This FY 2018 Malaria Operational Plan (MOP) presents a detailed implementation plan for Ethiopia, based on the strategies of PMI and the National Malari... Control Program (NMCP). It was developed in consultation with the Federal Ministry of Health (FMOH), NMCP, Ethiopian Public Health Institute (EPHI), and regional health bureaus, and with the participation of national and international partners involved in malaria prevention and control in the country. The activities that PMI is proposing to support align with the National Malaria Strategic Plan (NMSP 2014-2020) and build on investments made by PMI and other partners to improve and expand malaria-related services, including the Global Fund to Fight AIDS, Tuberculosis, and Malaria (Global Fund) malaria grants. This document briefly reviews the current status of malaria control policies and interventions in Ethiopia, describes progress to date, identifies challenges and unmet needs to achieving the targets of the NMCP and PMI, and provides a description of activities that are planned with FY 2018 funding.
The Creditor Reporting System was analysed for official development assistance funding disbursements towards TB control in 11 conflict-affectedstates, 17 non-conflict-affected fragile states and 38 comparable non-fragile states. The amounts of fundi...
The increasing amounts of official development assistance (ODA) for health have been aimed primarily at fighting HIV/AIDS, malaria and tuberculosis. Neglected tropical diseases (NTD), one ... the most serious public health burdens among the most deprived communities, have only recently drawn the attention of major donors. While frequently stated, the low share
of funding for NTD control projects has not been calculated empirically. Our analysis of ODA commitments for infectious disease control for the years 2003 to 2007 confirms that Development Assistance Committee (DAC)-countries and multilateral donors have largely ignored funding NTD control projects. On average, only 0.6% of total annual health ODA was dedicated
to the fight against NTDs while the average share of control projects for HIV/AIDS was 36.3%, for malaria 3.6%, and for tuberculosis 2.2%. This allocation of health ODA does not reflect the diseases’ respective health burdens.
Background
Asthma education, a key component of long-term asthma management, is challenging in resource-limited settings with shortages of clinical staff. Task-shifting educational roles to lay (no...
2nd edition. The interagency field handbook on malaria control was developed to set out effective malaria control responses in humanitarian emergencies, particularly during the acute phase when reli...
USAID/KENYA Evaluation Services and Program Support (ESPS)
The United States Agency for International Development (USAID) has a solid track record of supporting health and development initiatives in Kenya. AIDS, Population, and Health Integrate...
The United States Agency for International Development (USAID) has a solid track record of supporting health and development initiatives in Kenya. AIDS, Population, and Health Integrate...
On 15–16 December 2020, WHO and the Medicines for Malaria Venture co-convened a technical consultation to consider the preferred product characteristics (PPCs) for drugs used in malaria chemopreve...
This article examines the activities of national and international actors in Pharmaceutical Services (PS) in Mozambique from 2007 to 2012, focusing on the public provision of HIV/Aids, ... and tuberculosis medicines. It describes how PS functions in the country, what actors are involved in this area and the relations among them, pursuing salient issues in the modus operandi of partners in cooperation.
Healthy people, healthy animals and a healthy environment worldwide with the One Health approach.
The COVID-19 pandemic has drastically demonstrated just how close the link is between humans, animals, and the environment, and has highlighted and aggravated existing challenges. The destruction ... natural habitats and displacement of species, trade in wild animals, resource-intensive lifestyles and conditions, non-sustainable food systems and, in particular, industrial agriculture and intensive livestock farming are the causes of the emergence of zoonoses as well as numerous other communicable and non-communicable, chronic diseases.
The One Health approach focuses precisely on such interaction between humans, animals, and the environment.
This manual provides guidance on best practices to be followed in Ebola Care Units (ECUs)/Community Care Centres (CCCs). It is intended for health aid workers (including junior nurses and community health-care workers) and others providing care for patients in ECUs/CCCs. While the focus is on the ca...
The World Health Organization (WHO) defines mental health as ‘a state of well-being in which the individual realizes his or her own abilities, can cope with the normal stresses of life, can work p...
Malaria vaccine: WHO position paper - March 2022
recommended
Weekly Epidemiological Record No 9, 2022, 97, 61–80
This position paper supersedes the 2016 publication, “Malaria vaccine: WHO position paper-2016.”1 It includes the updated WHO recommendations on the wider use ... the RTS,S/AS01 vaccine for the reduction of malaria morbidity and mortality in children living in areas of moderate to high malaria transmission. It also incorporates findings from the evaluation of the WHO-coordinated Malaria Vaccine Implementation Programme (MVIP), recommended by SAGE and MPAG in 2015, and from additional studies since 2015.
This paper does not include findings on vaccine efficacy in infants first vaccinated at 6–12 weeks of age. Because of the lower vaccine efficacy observed in this age category, WHO did not recommend pilot implementation or RTS,S/AS01 vaccine introduction for these young infants. Recommendations2 on the use of RTS,S/AS01 vaccine were discussed by SAGE and MPAG during a joint session in October 2021; evidence presented at the meeting can be accessed at https://terrance.who.int/mediacentre/data/ sage/SAGE_eYB_Oct2021.pdf
